The role of intracellular Ca 2+ pools in the regulation of growth factor signal transduction pathways and mitogenesis is not well understood. We have examined the roles of basal and transiently mobilized Ca 2+ in the regulation of MAP kinases by EGF. To assess the in¯uence of Ca 2+ transients we utilized Plcg1 7/7 and Plcg1 +/+ mouse embryonic ®broblasts, while BAPTA/AM was employed to chelate total intracellular Ca 2+ in the same cell lines. The MAP kinases erk-1, erk-2 and erk-5 exhibited similar patterns of activation in wild-type and Plcg1 7/7 cells treated with EGF. However, pretreatment with BAPTA/AM signi®cantly increased and prolonged erk-1 and erk-2 activation in both cell types. In contrast, BAPTA/AM prevented the EGF activation of erk-5 in wild-type and Plcg1 7/7 cells. These data indicate that basal Ca 2+ , but not growth factor provoked Ca 2+ transients, has a signi®cant in¯uence on the activation of these MAP kinases. AG1478, a speci®c EGF receptor kinase inhibitor, abolished the prolonged erk-1 and erk-2 activation produced by EGF in cells pretreated with BAPTA/AM. This indicates that the prolonged activation of erk-1 and erk-2 produced in the presence of BAPTA/AM requires continuous signaling from the EGF receptor kinase.
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The role of intracellular Ca 2+ pools in the regulation of growth factor signal transduction pathways and mitogenesis is not well understood. We have examined the roles of basal and transiently mobilized Ca 2+ in the regulation of MAP kinases by EGF. To assess the in¯uence of Ca 2+ transients we utilized Plcg1 7/7 and Plcg1 +/+ mouse embryonic ®broblasts, while BAPTA/AM was employed to chelate total intracellular Ca 2+ in the same cell lines. The MAP kinases erk-1, erk-2 and erk-5 exhibited similar patterns of activation in wild-type and Plcg1
7/7
cells treated with EGF. However, pretreatment with BAPTA/AM signi®cantly increased and prolonged erk-1 and erk-2 activation in both cell types. In contrast, BAPTA/AM prevented the EGF activation of erk-5 in wild-type and Plcg1 7/7 cells. These data indicate that basal Ca
2+
, but not growth factor provoked Ca 2+ transients, has a signi®cant in¯uence on the activation of these MAP kinases. AG1478, a speci®c EGF receptor kinase inhibitor, abolished the prolonged erk-1 and erk-2 activation produced by EGF in cells pretreated with BAPTA/AM. This indicates that the prolonged activation of erk-1 and erk-2 produced in the presence of BAPTA/AM requires continuous signaling from the EGF receptor kinase. Oncogene (2000) 19, 1853 ± 1856.
Keywords: calcium; MAP kinase; EGF Mitogenic stimulation of cells inevitably produces a rapid change in the intracellular pool of free Ca 2+ (Clapham, 1995) , regardless of the stimulating agent employed. In resting cells, this intracellular concentration of free Ca 2+ in the cytosol is estimated to be approximately 100 nM or less. In mitogenically-stimulated cells stored Ca 2+ is rapidly released from intracellular sites, such as the endoplasmic reticulum, to raise the levels of cytosolic Ca 2+ to near 1 mM, which may contribute to consequent Ca 2+ increases in other cell compartments, such as the nucleus (Berridge, 1995) . In cells stimulated with agents that activate receptor and non-receptor tyrosine kinases, Ca 2+ mobilization depends on the tyrosine phosphorylation of phospholipase C-g (PLC-g) isozymes that facilitate the hydrolysis of phosphatidylinositol 4,5-bisphosphate to produce the second messenger molecules inositol 1,4,5-trisphosphate and diacylglycerol (Rhee and Bae, 1997; Kamat and Carpenter, 1997) . The former metabolite mediates Ca 2+ mobilization, while the latter serves as an endogenous activator of protein kinase C (Berridge and Irvine, 1984) .
It is generally considered that the amplitude and duration of Ca 2+ mobilization is the active component of Ca 2+ contributions to signal transduction pathways and cellular responses (Berridge, 1995; Dolmetsch et al., 1997 Dolmetsch et al., , 1998 Li et al., 1998) . Often Ca 2+ signaling occurs in concert with other signaling pathways to produce a mitogenic response. For example, stimulation of T cell proliferation requires antigen-dependent signaling from both Ca 2+ mobilization and the Rasmitogen-activated protein (MAP) kinase pathway to activate, respectively, the transcription factors NF-AT and AP-1 that lead to increased expression of interleukin-2 mRNA (Clements et al., 1999) .
Once cells are treated with a mitogen, however, it is experimentally dicult to distinguish possible contributions of basal Ca 2+ compared to mobilized Ca
. We have devised an experimental protocol that allows separate determinations of the possible contributions of basal and mobilized Ca 2+ to signal transduction pathways in growth factor-treated cells. This protocol has been employed to evaluate the role of these two Ca 2+ pools in the epidermal growth factor (EGF) activation of MAP kinases, a central component of the mitogenic response and a signi®cant contributor to tumorigenesis (Sebolt-Leopold et al., 1999) . Various MAP kinase isoforms are designated as extracellular signal regulated kinases (erk).
To determine the in¯uence of mobilized Ca 2+ on EGF-induced erk-1 and erk-2 activation, we compared this response in mouse embryo ®broblasts (MEF) that are wild-type (Plcg1
) at the Plcg1 locus. These cell lines were prepared from Plcg1 wild-type and nullizygous embryos derived from gene targeting experiments . The inability of the Plcg1 7/7 cells to mobilize intracellular Ca 2+ in response to EGF or platelet-derived growth factor has been previously reported (Ji et al., 1997) and more recently (Ji et al., 1999) for the same cells described in this report. As shown in Figure 1 (lanes 1 ± 4), these MAP kinase isoforms are transiently activated, as detected with antibody to the dual phosphorylated enzymes, in both Plcg1 , consistent with previously reported data (Ji et al., 1998) . The only minor distinction is that the activated form of erk-2 (pp42) but not erk-1 (pp44) is somewhat more prolonged in Plcg1 7/7 cells. To assess the role of the total intracellular pool of free Ca 2+ in this growth factor response, both cell lines were pretreated with BAPTA/AM [1,2-bis(2aminophe-noxy)ethane N,N,N',N'-tetraacetic acid tetra (acetoxymethyl) ester] prior to the addition of EGF. BAPTA/ AM enters cells and, following activation by hydrolysis of an ester bond by cellular enzymes, chelates intracellular free Ca
. As shown in Figure 1 (lanes 4 ± 8), BAPTA/AM pretreatment enhanced both the magnitude and duration of erk-1 and erk-2 activation by EGF in both cell lines. Scanning densitometry indicated that BAPTA/AM increased erk-1 and erk-2 activation by EGF by approximately two-and fourfold at 20 and 60 min, respectively. Since Plcg1 7/7 cells do not mobilize Ca 2+ in response to growth factors (Ji et al., , 1999 , a comparison of the results in these cell lines with and without BAPTA/AM exposure leads to the conclusion that basal intracellular free Ca 2+ has a signi®cant role in determining the extent and duration of EGF-dependent activation of erk-1 and erk-2. Exposure of cells to BAPTA/AM in the absence of EGF had no in¯uence on the activity of these MAP kinase isoforms, indicating that the BAPTA/AM in¯uence is secondary to the primary mechanism of stimulation by EGF, i.e. Ras activation. Control experiments have shown that the extracellular Ca 2+ is not necessary for the BAPTA/AM potentiation of erk-1 and erk-2 activation by EGF. The addition of neither EGTA, to chelate extracellular Ca 2+ , nor ni®derpine, a Ca 2+ channel blocker, altered the BAPTA/AM in¯u-ence on the activation of these MAP kinases in this system (data not shown).
If BAPTA/AM does increase and prolong erk-1 and erk-2 activation, then cellular downstream responses would also be expected to be increased by this protocol. These MAP kinase isoforms are known to participate in the growth factor-induced expression of c-fos mRNA by the phosphorylation of the transcription factor Elk-1 (Treisman, 1996) . Therefore, we have determined the in¯uence of BAPTA/AM on c-fos expression in Plcg1 +/+ and Plcg1 7/7 cell lines. As shown in Figure 2 (lanes 1 ± 4) , c-fos mRNA was very transiently expressed following EGF addition to both cell lines. However, in BAPTA/AM pretreated cells the duration of c-fos expression was increased from 30 to 60 min in both cell lines, consistent with the increased duration of erk-1 and erk-2 activation achieved in the presence of BAPTA/AM. It is possible that the observed BAPTA/AM enhanced activation of these MAP kinases could result from prolonged activation of the EGF receptor. The experiment shown in Figure 3 , however, indicates that BAPTA/AM pre-incubation does not increase the level or duration of growth factor-dependent tyrosine phosphorylation of the EGF receptor in Plcg1 +/+ cells. Similar results were obtained with the Plcg1 7/7 cells (data not shown). To test whether the in¯uence of BAPTA/AM on the activation of the MAP kinases erk-1 and erk-2 is selective, we examined the activation of erk-5, a member of the MAP kinase family that is also activated by EGF (Kato et al., 1998; Kamakura et al., 1999) . The results shown in Figure 4 demonstrate that erk-5 is activated by EGF in both Plcg1 +/+ and Plcg1 7/7 cells, as detected by a band shift indicative of phosphorylation. Interestingly and in contrast to the EGF activation of erk-1 and erk-2, BAPTA/AM blocked the activation of erk-5 in both cell types. These results indicate that basal Ca 2+ , but not transiently mobilized Ca 2+ , is necessary for the activation of erk-5 by EGF.
We then used the selective EGF receptor tyrosine kinase inhibitor AG1478 to determine whether the capacity of BAPTA/AM to enhance erk-1 and erk-2 activation requires continuous signaling from the EGF receptor. The kinase inhibitor AG1478 is highly selective toward the EGF receptor and rapidly enters cells to inhibit the tyrosine kinase activity of this receptor (Levitzki and Gazit, 1995; BoÈ hmer et al., 1995) . In this experiment, wild-type cells were pre- Figure 1 In¯uence of BAPTA/AM on erk-1 and erk-2 Activation in Plcg1 +/+ and Plcg1 7/7 MEF. Cells were grown to near con¯uence in Dulbecco's Modi®ed Eagle Medium (DMEM) and 10% fetal calf serum, starved arrested by incubation overnight in DMEM plus 0.1% calf serum. After washing the culture, DMEM plus 0.1% BSA was added and the cells were preincubated for 20 min in 30 mM BAPTA/AM (Molecular Probes, Inc.). EGF (25 ng/ml) was then added to the indicated dishes and the cells were incubated for the indicated periods of time. At each time point, the cells were washed twice in ice-cold PBS and lysed in icecold TGH buer (1% Triton X-100, 10% Glycerol, 50 mM HEPES, pH 7.2) supplemented with 100 mM NaCl and protease and phosphatase inhibitors (10 mg/ml aprotinin, 10 mg/ml leupeptin, 100 mM phenylmethlysulfonyl¯uoride, 1 mM Na 3 V0 4 ) for 10 min at 48C with rocking. The lysates were clari®ed by centrifugation (13 000 g, 10 min) and aliquots (80 mg protein) were subjected to SDS ± PAGE. After electrophoretic transfer to nitrocellulose, the membranes were blotted with rabbit antibody that detects the dual phosphorylated form of erk-1 and erk-2 (Promega). Bound antibody was detected after washing by enhanced chemiluminescence (ECL) Figure 2 In¯uence of BAPTA/AM on the EGF Induction of cfos mRNA. Cells were prepared as previously described and preincubated with BAPTA/AM (20 min, 30 mM) prior to the addition of EGF (25 ng/ml). At the indicated times total cellular RNA was isolated using a Qiagen kit according to the manufacturer's instructions (Qiagen). For each data point an aliquot (10 mg) or total RNA was electrophoresed, transferred to a nylon membrane (Bio-Rad), and probed according to standard procedures. To detect c-fos mRNA, a 1,0 kb EcoRI-BamHI fragment of c-fos (a gift from Ron Wisdom, Vanderbilt University) was used. A probe for glyceraldehyde-3-phosphate dehydrogenase also was used and was obtained from Dr Ron Wisdom. The probes were labeled with a 32 P-'dCTP using the Prime-It II random primer labeling kit (Stratagene) incubated with or without BAPTA/AM as described previously. EGF was then added and AG1478 was added 5 min later to approximately one-half of the BAPTA/AM pretreated cells, as indicated in Figure 5 . At various times following the addition of EGF, EGF receptor tyrosine phosphorylation and erk-1 and erk-2 activation were assessed by appropriate Western blotting. The data in the upper panel, depicting levels of EGF receptor tyrosine phosphorylation, show a rapid decrease in receptor activation within 2.5 min after the addition of AG1478, i.e. at 7.5 min following EGF addition. In this experiment the presence of BAPTA/AM increased the duration of erk-1 and erk-2 activation: Figure 5 , compare lanes 4 ± 8 (without BAPTA/AM) and lanes 9 ± 13 (with BAPTA/AM). The data in Figure 5 (lanes 14 ± 18) show that addition of AG1478 to cells preincubated with BAPTA/AM prevented the increased duration of erk-1 and erk-2 activation provoked by EGF. Similar results were obtained with Plcg1 7/7 cells (data not shown). This demonstrates that the BAPTA/AM enhancement of erk-1 and erk-2 activation does not require continuous signaling from the EGF receptor.
The results described above suggest that basal intracellular Ca 2+ has a negative role in the activation of erk-1 and erk-2. One possible mechanism that would ®t this function is the Ca 2+ -dependent induction of MAP kinase phosphatases, as described by Cook et al. (1997) and Scimeca et al. (1997) . Several dual phosphatases that dephosphorylate erk-1 and erk-2 have been identi®ed in various cell types and some are known to be immediate early genes expressed following growth factor addition to cells (Guan and Butch, 1995; Keyse and Emslie, 1992; Rohan et al., 1993) . Our data are in agreement with that of Cook et al. (1997) but indicate that it is basal intracellular Ca 2+ and not growth factor-induced Ca 2+ transients that participate in the control of erk-1 and erk-2 activation. However, it is also possible that the control of erk-1 and erk-2 activation by basal Ca 2+ occurs upstream of these MAP kinases and downstream from the EGF receptor.
The control of erk-5 activation by growth factors is substantially less well understood than that of erk-1 and erk-2. Similar to other MAP kinases, erk-5 Figure 3 EGF receptor tyrosine phosphorylation in the presence and absence of BAPTA/AM. Wild-type cells were prepared as previously described, preincubated with 30 mM BAPTA/AM for 20 min, and then EGF (25 ng/ml) was added. The cells were washed and lysed as in Figure 1 . Equal aliquots (1 mg) or each lysate was immunoprecipitated with anti-EGF receptor (Stoscheck and Carpenter, 1983) . After SDS gel electrophoresis and transfer to nitrocellulose, the membrane was probed with anti-phosphotyrosine (Zymed). Bound antibody was detected by ECL Figure 4 In¯uence of BAPTA/AM on erk-5 Activation in Plcg1 +/+ and Plcg1 7/7 MEF. Cells were prepared as previously described and preincubated with or without BAPTA/AM (30 mg) for 20 min prior to the addition of EGF (25 ng/ml) for an additional 20 min. As described in Figure 1 , the cells were then washed and lysed in TGH buer. Lysates were centrifuged and aliquots (80 mg protein) were subjected to SDS ± PAGE and then transferred to nitrocellulose. The membranes were blotted with rabbit antibody to erk-5 as described by Kato et al. (1998) . Bound antibody was detected after washing by ECL Figure 5 In¯uence of inhibition of EGF receptor tyrosine kinase activity of the BAPTA/AM enhanced activation of erk-1 and erk-2 by EGF. Wild-type cells were prepared as previously described and pretreated without or with BAPTA/AM for 20 min, and then EGF (25 ng/ml) was added for 5 min. The cells were further added AG1478 (150 mg/ml) for the indicated periods of time. EGF receptor tyrosine phosphorylation was detected by immunoprecipitation and Western blotting as described in Figure 3 (top panel) . The same cell lysates were also used to measure the MAP kinase activation using the antibody to the dual phosphorylated erk-1 and erk-2 that was used in Figure 1 (lower panel) activation by growth factor is thought to depend on Ras, Raf, and a dual kinase MEK-5 (English et al., 1998 (English et al., , 1999 Kamakura et al., 1999; Kato et al., 1997; Zhou et al., 1995) . Interestingly, however, activation of erk-5 by oxidation with H 2 O 2 (Abe et al., 1996) or¯uid shear stress (Yan et al., 1999) is blocked by depletion of intracellular Ca 2+ . Our data show a similar in¯uence using BAPTA/AM, and that erk-5 is activated in the presence or absence of PLC-g1. This would suggest that erk-5 activation by EGF requires basal Ca 2+ , but not transiently mobilized Ca 2+ . In general, relatively little attention is focused on the role of basal Ca 2+ in signaling pathways relevant to mitogenesis. These data suggest a secondary role for basal Ca 2+ relative to primary signaling pathways, but a role that has a signi®cant input into the ®nal outcome.
